Rochester, NY 7/28/2009 4:17:24 AM
Mylan Inc. MYL, Quality control a factor in stock dip
Mylan Inc.
The world's 3rd largest generic drugmaker is being investigated by U.S regulators and their stock dipped 13% following a newspaper citing quality control issues.
http://WhisperFromWallStreet.com offers daily stock alerts to subscribers. Sign up for our free alerts newsletter.
"We are currently fact-finding and investigating this situation," said Christopher Kelly, a spokesman for the U.S. Food and Drug Administration.
Mylan was at the ready with an email defense, questioning the conclusions and sources in the newspaper article.
WhisperfromWallStreet.com is a FREE award winning newsletter that specializes in sending alerts to our subscribers on stocks we think are going to run, why we think so, as well as teaching you how to become a better trader. We scan hundreds of stocks a day to find those that meet our criteria and when we find one, we send you an alert.
Sign up for our FREE alerts newsletter at WhisperfromWallStreet.com
Disclaimer: Full disclaimer at http://whisperfromwallstreet.com/disclaimer.php
IMPORTANT: Never invest in any stock featured in any press release, email or website unless you can afford the loss of your entire investment. Stocks and particularly penny stocks have the possibility for dramatic gains, and also losses. Neither WhisperFromWallStreet, nor any of its affiliates are registered investment advisors or broker dealers.
